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Effectiveness of continuous glucose monitoring in pregnant
women with diabetes: randomised clinical trial
Helen R Murphy,1 Gerry Rayman,1 Karen Lewis,1 Susan Kelly,2 Balroop Johal,3 Katherine Duffield,4
Duncan Fowler,1 Peter J Campbell,5 Rosemary C Temple4
ABSTRACT
Objective To evaluate the effectiveness of continuous
glucose monitoring during pregnancy on maternal
glycaemic control, infant birth weight, and risk of
macrosomia in women with type 1 and type 2 diabetes.
DesignProspective, open label randomisedcontrolled trial.
Setting Two secondary care multidisciplinary obstetric
clinics for diabetes in the United Kingdom.
Participants71womenwith type1diabetes (n=46)or type
2 diabetes (n=25) allocated to antenatal care plus
continuous glucose monitoring (n=38) or to standard
antenatal care (n=33).
Intervention Continuous glucose monitoring was used as
an educational tool to inform shared decisionmaking and
future therapeutic changes at intervals of 4-6 weeks
during pregnancy. All other aspects of antenatal carewere
equal between the groups.
Main outcome measures The primary outcome was
maternal glycaemic control during the second and third
trimesters from measurements of HbA1c levels every four
weeks. Secondary outcomes were birth weight and risk of
macrosomia using birthweight standard deviation scores
and customised birthweight centiles. Statistical analyses
were done on an intention to treat basis.
ResultsWomen randomised to continuous glucose
monitoring had lower mean HbA1c levels from 32 to
36 weeks’ gestation compared with women randomised to
standard antenatal care: 5.8% (SD 0.6) v 6.4% (SD 0.7).
Compared with infants of mothers in the control arm those
of mothers in the intervention arm had decreased mean
birthweight standard deviation scores (0.9 v 1.6; effect size
0.7 SD, 95% confidence interval 0.0 to 1.3), decreased
median customised birthweight centiles (69% v 93%), and
a reduced risk of macrosomia (odds ratio 0.36, 95%
confidence interval 0.13 to 0.98).
Conclusion Continuous glucose monitoring during
pregnancy is associated with improved glycaemic control
in the third trimester, lower birth weight, and reduced risk
of macrosomia.
Trial registration Current Controlled Trials
ISRCTN84461581.
INTRODUCTION
Macrosomia (infant birth weight ≥90th centile for sex
and gestational age) remains the commonest
complication of pregnancy in women with diabetes,
leading to increased risk of perineal lacerations,
complications in labour, and delivery by caesarean
section.1 For the infants the risks of immediate
complications are increased, as well as the longer
term risks of insulin resistance, obesity, and type 2
diabetes.2 3
Data from theNetherlands suggest that near optimal
glycaemic control during early pregnancy failed to
reduce the risk of macrosomia, present in 48.8%
infants.4 This prompted us to consider new strategies,
focusing on reducing postprandial hyperglycaemic
spikes during the second and third trimesters.
Novel methods of continuous glucose monitoring
provide up to 288measurements a day.5 6Detailed data
on the magnitude and duration of glucose fluctuations
give insights into daily glycaemic control, especially
valuable during the physiological changes of
pregnancy.6 Continuous monitoring also provides
patients with visual feedback on the consequences on
glycaemia of factors such as diet, which can be
harnessedas apowerful educational tool.Weevaluated
the effectiveness of antenatal continuous glucose
monitoring on maternal glycaemic control and birth
weight and risk of macrosomia in the offspring of
mothers with diabetes.
METHODS
From September 2003-6 we carried out a prospective,
open label randomised controlled trial at two multi-
disciplinary diabetic antenatal clinics in the United
Kingdom. We compared intermittent self monitoring
of blood glucose with continuous glucose monitoring
in pregnant women aged 16-45 with type 1 and type 2
diabetes. Overall, 71 of 93 (76%) consecutively
approached women, representative of women attend-
ing the clinics (see bmj.com), agreed to participate.
Forty six (65%) women had type 1 diabetes and 25
(35%) had type 2 diabetes. We offered continuous
glucose monitoring for up to seven days at intervals of
4-6 weeks between 8 and 32 weeks’ gestation.6 The
sensor was inserted at the hospital and data were
downloaded after oneweek. Thewomenwere asked to
identify patterns in hypoglycaemia and hyperglycae-
mia. They were advised to consider these and to
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suggest possible solutions such as changes to insulin
dose, diet, and activity. The suggested changes were
then discussed with the diabetes team.
We advised all women to measure blood glucose
levels at least seven times aday, aiming for the targets of
3.5-5.5 mmol/l before meals, <7.8 mmol/l one hour
after meals, and <6.7 mmol/l two hours after meals.
The women were seen every 2-4 weeks for up to
28 weeks, fortnightly until 32 weeks, and weekly
thereafter, with assessments of fetal growth at 28, 32,
and 36 weeks. Women with type 2 diabetes were
treated with insulin before pregnancy or when
pregnancy was confirmed.
HbA1c levels weremeasured once every four weeks.
We calculated the birthweight standard deviation
scores for only liveborn singletons.7 Customised
birthweight centiles8 were calculated using maternal
height, weight, ethnicity, and parity; neonatal sex; and
gestational age, with twin standards used for twin
pregnancies.9
Statistical analysis
We compared the baseline characteristics of the
women using Fisher exact tests for discrete variables
and t tests for continuous variables. For glycaemic
control, we allocated the HbA1c measurements to
windows of four weeks, and compared the two arms
using t tests. We also used a t test to compare the
standarddeviation scores for birthweight.As a result of
the heavily skewed distribution of birthweight centiles,
we compared these between the two arms using the
non-parametric Wilcoxon rank sum test, and we used
Fisher exact tests to compare thepresenceor absenceof
macrosomia. We used binomial tests for testing
whether the proportion of small for gestational age
infants was different from 10%. All analyses were done
on an intention to treat basis, with statistical signifi-
cance set at 5%.
We excluded three infants in each group from the
analyses of mean birth weight, birthweight centile, and
birthweight standard deviation score owing to
miscarriage, neonatal death, and major malformation
(see bmj.com). For birthweight standard deviation
scores we included only healthy singletons (n=62), as
no comparative standard exists for twins. We did the
analyses for birthweight centile with twins (n=67),
using the appropriate centile reference range for twins,9
and without twins (n=62).
RESULTS
Overall, 38 women were randomised to continuous
glucose monitoring and 33 to standard antenatal care.
The mean age of participants was 31.3 (SD 6.1) years,
mean body mass index 28.1 (SD 7.4), and mean
duration of diabetes 12.8 (SD 0.3) years (see bmj.com).
At booking the mean HbA1c level was 7.3% (SD 1.2%)
andmeangestational age9.2 (SD2.7)weeks.Except for
duration of diabetes, the groups were similar.
The continuous glucose monitor was generally well
tolerated. Themean number of periods for continuous
monitoring in 36 women (two pregnancies ended) was
4.2 (range0-8),with29of thewomen (80%)wearing the
monitor at least once per trimester. Two women
withdrew.
Glycaemic control
Although theHbA1c level was consistently lower in the
intervention arm no statistical difference was found in
mean levels between the two groups at booking or
throughout the first two trimesters (figure). Between 28
and 32 weeks’ gestation the mean HbA1c level in the
intervention arm was 6.1% (SD 0.6) compared with
6.4% (SD 0.8) in the control arm, with a trend towards
but not reaching statistical significance (P=0.1). At
32-36 weeks’ gestation a further reduction in HbA1c
levels occurred in the intervention arm but not the
control arm.
Pregnancy outcomes
From 71 pregnancies there were 69 living infants
(table). One woman in each armmiscarried in the first
trimester andonewomanhad a termination.Two early
neonatal deaths occurred (one in each arm); a twin
pregnancy with the death of one twin at 34 weeks’
gestation (anencephaly) and another at 28 weeks’
gestation (Edward’s syndrome). Two sets of twins plus
the twin of the anencephalic infant resulted in five
healthy twins (offspringofwomen in interventionarm).
Two live infants had malformations, one cardio-
vascular (control arm) and one chromosomal (inter-
vention arm).
Birth weight
Compared with healthy singletons of women in the
control group (n=30), those of women in the inter-
vention group (n=32) had decreasedmean birthweight
standard deviation scores (0.9 v 1.6; effect size 0.7 SD,
95% confidence interval 0.0 to 1.3; P=0.05). The
median birthweight centiles for 67 of 69 healthy live
infants were 69% in the intervention group and 93% in





















Antenatal care plus continuous glucose monitoring
Mean HbA1c levels every four weeks in women receiving
standard antenatal care (n=33) or antenatal care plus
continuous glucose monitoring (n=38). Vertical lines are
standard deviation at each time point
RESEARCH
908 BMJ | 18 OCTOBER 2008 | VOLUME 337
The difference remained significant after exclusion of
the twins (P=0.04).
In total, 31 of 67 (46%) infants were macrosomic, of
whom 23 were born to mothers with type 1 diabetes
(74%) and eight to mothers with type 2 diabetes (26%).
Thirteenof37 (35%) infants in the interventionarmhad
macrosomia compared with 18 of 30 (60%) in the
control arm (odds ratio 0.36, 95% confidence interval
0.13 to 0.98; P=0.05). Fewer extremely large for
gestational age infants were born to mothers in the
intervention arm than the control arm: 5/37 (13.5%) v
9/30 (30%). This difference did not reach statistical
significance (P=0.13). The two largest infants born to
mothers in the intervention arm (see bmj.com) were
born to mothers who withdrew from the intervention
(included in intention to treat analysis).
One infant of amother in the intervention arm had a
birthweight standard deviation score below −2 (see
bmj.com). She was delivered at gestational age
34 weeks to a primiparous mother with severe pre-
eclampsia. On the basis of the birthweight centile
definition of small for gestational age, four of 37 (11%)
infants ofwomen in the intervention armwere small for
gestational age comparedwith 0of 30 infants ofwomen
in the control arm (P=0.1). Formal testing showed that
the number of small for gestational age infants in the
intervention arm was no different from that expected
(11% v 10%; P=1.0), whereas in the control arm fewer
babies than expected were below the 10th centile (0%;
P=0.07).
DISCUSSION
Use of supplementary continuous glucose monitoring
as an educational tool during pregnancy is associated
with improvedmaternal glycaemic control.The infants
of mothers in the intervention arm had a lower birth
weight and a reduced risk of macrosomia than those of
mothers in the control arm (standard antenatal care).
The observed differences in maternal HbA1c levels,
reflecting mean blood glucose levels over the preced-
ing 4-6 weeks, emerged at 28 weeks’ gestation but did
not reach statistical significance until after 32 weeks.
We consistently found improvements in glycaemic
profiles that were achieved gradually rather than after
one consultation (data not shown), emphasising the
importance of using the continuous glucose monitor-
ing profile as a tool to facilitate patient education and
shared problem solving. That HbA1c levels do not
improve until the third trimester may reflect the delay
between improved glycaemic control and clearance of
glycated haemoglobin from the circulation.
Several possible explanations may contribute to the
observed improvements in maternal and neonatal
outcomes. Generally, women measure their blood
glucose levels before and after meals, with only the
mostmotivatedachieving the suggested10daily tests.10
The continuous glucose monitoring profiles yielded
maximal information about the frequency,magnitude,
and duration of glucose excursions and may have
contributed to increased motivation and compliance
with self management, in particular glucose testing
after meals among women in the intervention group.
The visual impact of continuous monitoring focused
input towards reducing hyperglycaemic spikes, which
are less apparent from a diary or glucose meter
download. The data also provided feedback on the
adequacy of prandial and basal insulin levels, day to
day variability in diet, physical activity, and manage-
ment of hypoglycaemia, with positive feedback to re-
enforce optimal self management.
The relative contribution of hyperglycaemia com-
pared with obesity in the development of macrosomia
is controversial.11 We therefore adjusted the birth-
weight centiles for maternal height and weight and
baseline maternal body mass indices were similar in
both groups. The observed differences in birth weight
are most likely attributable to the improvements
obtained in glycaemic control.
Althoughwe cannot exclude the possibility that tight
glycaemic control contributed to fetal growth restric-
tion, onlyone infantof amother in the interventionarm
had a birthweight standard deviation score below−2. It
is of note that no infants of mothers in the control arm
were born small for gestational age.
Strengths and limitations of the study
This trial combined recent advances in glucose
monitoring with a pragmatic educational approach,
Pregnancy outcome inwomenwith pregestational diabetes allocated to standard antenatal care plus continuous glucose






Mean (SD) birthweight standard deviation score* 0.9 (1.0) 1.6 (1.4) 0.05
Mean (SD) birth weight (g)† 3340 (760) 3630 (500) 0.07
Median birthweight centile† 69 93 0.02
Macrosomia (≥90th centile) 35 (13) 60 (18) 0.05
Extremely large for gestational age (≥97.7th centile) 14 (5) 30 (9) 0.1
Small for gestational age (≤10th centile) 11 (4) 0 0.1
*Scores calculated only for 62 healthy living singletons (32 in intervention arm, 30 in control arm).
†Calculations were done for 67 of 69 healthy living infants (37 in intervention arm, 30 in control arm), after excluding one infant from each group as a
result of congenital or chromosomal malformation. Twins are included, with centiles calculated using specific twin standards. Difference in birthweight
centiles remained significant (P=0.04) when twins were excluded.
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suitable for implementation in real life clinical settings.
It fills a gap identified by the National Institute for
Health and Clinical Excellence for more research into
continuous glucose monitoring and diabetes related
morbidity, including pregnancy complications and
neonatal outcomes. Furthermore, recruitment and
retention rates were high and 76% of women partici-
pated. Despite the inconvenience of wearing a sensor,
80% of women used continuous glucose monitoring at
least once per trimester.
Some limitations should also be considered. Firstly,
the women were predominantly of white European
ethnicity,whichmay limit applicability towomen from
other ethnic backgrounds. Secondly, health profes-
sionals were not blinded and therefore we cannot fully
exclude the possibility of bias in clinical management.
We attempted to standardise antenatal contacts
between groups, with no difference in the frequency
or duration of clinical appointments, dietary advice,
obstetric input, or fetal surveillance, and no clinical
input during attachment of the sensor. Thirdly,
differences in maternal characteristics, with longer
duration of diabetes in the intervention group, perhaps
contributed to some of the effect on infant outcomes,
although would not explain the improvements in
glycaemic control. Fourthly, the sample size was small.
Putting the study in context and implications
Our study has filled an important gap in the evidence
base,12 suggesting that new technologies can be used to
reduce the risk of diabetes related complications in
pregnancy. Continuous glucose monitoring can pro-
vide added benefits to the pregnancy outcomes for
women with diabetes and their infants. Additional
benefits on intention to treat analysis were a reduction
inHbA1c levels in the third trimester and reduced birth
weight and risk of macrosomia. The observed reduc-
tions in birth weight are particularly important in view
of the widespread prevalence of macrosomia, affecting
over half of all infants born to mothers with diabetes in
the United Kingdom. These large for gestational age
infants have an increased longer term risk of insulin
resistance, obesity, and type 2 diabetes.
Although rates of macrosomia were reduced in
women using continuous glucose monitoring, they
remain 3.5 times higher than the general maternity
population. This suggests that although continuous
monitoring assists women to improve average
glycaemic control in late pregnancy, it is still
inadequate for achieving optimal day to day glucose
control and birth weights comparable with the
background population.We have shown that supple-
mentary continuous glucose monitoring provided in
a routine clinical setting leads to better glycaemic
control and reduced risk ofmacrosomia. If confirmed
by other studies these data have important implica-
tions for the antenatal management of women with
diabetes as well as the immediate and longer term
health of their infants.
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WHAT IS ALREADY KNOWN ON THIS TOPIC
Continuous glucose monitoring is a potentially beneficial
educational tool, with benefits on glycaemic control
NICE have called for research during pregnancy, to focus on
pregnancy complications and infant outcomes
WHAT THIS STUDY ADDS
Continuous glucosemonitoring is associatedwith improved
maternal glycaemic control and reduced infant birth weight
and risk of macrosomia
The beneficial effects on pregnancy complications
potentially offer longer termhealthbenefits for the infants of
mothers with diabetes
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Commentary: The technology of continuous glucose
monitoring
Mary H Charlton
The continuous glucose monitor used by Murphy and
colleagues can be thought of as diabetology’s answer to
cardiology’s 24 hour electrocardiography monitor. It is
used as an investigative tool, is attached to the patient
(usually for 72 hours), and requires the user to return to
hospital for its removal. The data are downloaded and
examined for abnormal glucose levels and trends.
The sensor is inserted through the abdominal wall, so
that its glucose oxidase tip lies within subcutaneous
tissue, where it measures the glucose level of interstitial
fluid, not of blood. The sensor is wired to a palm sized
monitor, which can be clipped to clothing. The sensor
cannot be disconnected, even temporarily—for exam-
ple, when showering. The monitor captures and stores
the average glucose measurement every five minutes,
yielding 288 readings in 24 hours.1
The patient is taught to key in the times of food,
exercise, insulin, and symptoms of hypoglycaemia. The
device also requires at least four self monitored blood
glucose readings to be entered each day for calibration,
obtained by finger prick.
The device used by Murphy and colleagues does not
give“real time” readings;bothpatientandprofessionalare
unaware of themeasurements until the end of the 3-7 day
period of recording, determined by the life of the sensor.
Thedataare thendownloaded.Softwareensuresadequate
correlation between the sensor’s interstitial fluid readings
and the more reliable2 self monitored glucose readings.
Continuous glucose monitoring “fleshes out” the
information obtained from conventional self monitored
glucose readings, helping inform changes to manage-
ment and providing a graphic educational tool. Such
monitoring is oftenusedwhenpatients andprofessionals
cannot reconcile self monitored readings with those of
measured HbA1c levels. Its usefulness in this situation
seems limited.3 More specific indications are suspected
asymptomatic nocturnal hypoglycaemia especially with
“rebound” hyperglycaemia; suspected “dawn phenom-
enon”—when endogenous corticosteroids drive blood
glucose levels up to a misleadingly normal or high level
on waking; unawareness of hypoglycaemia; pregnancy,
when postprandial hyperglycaemia needs tight control;
and proved or suspected gastroparesis, when postpran-
dial hyperglycaemia is unpredictable.
Continuous glucose monitors cost around £2000
(€2509; $3566) and each sensor around £50.4 The
accuracy of the monitor is limited2 especially at lower
glucose levels, and readings still require validation with
those of the self monitored blood glucose. A lag exists
between changes in blood glucose levels and those of
interstitial fluid, and readings from interstitial fluid are
slightly lower than those from blood. This is of particular
concern at times of rapidly changing blood glucose levels
and in hypoglycaemia. The National Institute for Health
andClinicalExcellencehasyet toappraise the technology.
Real time continuous glucosemonitoring displays the
most recent glucose reading and alerts the user when a
preset glucose range is breached. The advantages of
rapid response, particularly to hypoglycaemia, are
evident but in practice there are problems with false
alarms; the temptation togiveextra insulin sooften that it
accumulates, causing hypoglycaemia; the temptation
not to validate with self monitored blood glucose
readings; and the psychological morbidity of being
attached to a device for a defined period.
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Does a functional activity programme improve function,
quality of life, and falls for residents in long term care?
Cluster randomised controlled trial
Ngaire Kerse,1 Kathy Peri,2 Elizabeth Robinson,3 Tim Wilkinson,4 Martin von Randow,5 Liz Kiata,1
John Parsons,2 Nancy Latham,6 Matthew Parsons,2 Jane Willingale,7 Paul Brown,7 Bruce Arroll1
ABSTRACT
Objective To assess the effectiveness of an activity
programme in improving function, quality of life, and falls
in older people in residential care.
Design Cluster randomised controlled trial with one year
follow-up.
Setting41 low leveldependency residential carehomes in
New Zealand.
Participants 682 people aged 65 years or over.
Interventions330 residentswere offereda goal setting and
individualised activities of daily living activity programme
by a gerontology nurse, reinforced by usual healthcare
assistants; 352 residents received social visits.
Main outcome measures Function (late life function and
disability instruments, elderly mobility scale, FICSIT-4
balance test, timed up and go test), quality of life (life
satisfaction index, EuroQol), and falls (time to fall over
12 months). Secondary outcomes were depressive
symptoms and hospital admissions.
Results 473 (70%) participants completed the trial. The
programme had no impact overall. However, in contrast to
residents with impaired cognition (no differences between
intervention and control group), those with normal
cognition in the intervention group may have maintained
overall function (late life function and disability instrument
total function, P=0.024) and lower limb function (late life
function and disability instrument basic lower extremity,
P=0.015). In residents with cognitive impairment, the
likelihood of depression increased in the intervention
group. No other outcomes differed between groups.
Conclusion A programme of functional rehabilitation had
minimal impact for elderly people in residential care with
normal cognition but was not beneficial for those with
poor cognition.
Trial registration Australian Clinical Trials Register
ACTRN12605000667617.
INTRODUCTION
Elderly people with high levels of habitual physical
activity live longer and have better general health and
higher levels of wellbeing than do those who are
inactive.1 However, for very frail elderly people in
residential care, the potential for such activity is limited.
Sustainableways to slow functional decline in residential
carehavenot yet been identified.Wereport the resultsof
a pragmatic cluster randomised controlled trial that
followsa successful efficacy trial,which suggested that an
intervention based on activities that are meaningful to
the individual person can be effective in improving
quality of life for elderly people in residential care.2
METHODS
Participants and recruitment
Residents in low level dependency residential care in
two cities of New Zealand were eligible for this study.3
We invited homes to participate in random order by
using computer generated random numbers.
Eligible residents were aged 65 years and over, able
to engage in a conversation about a goal, remember the
goal, and participate in a programme to achieve the
goal. We excluded residents who were unable to
communicate to complete the study measures, had
anxiety as theirmain diagnosis,were acutely unwell, or
were in a terminal state. We recruited residents
between February and November 2004 and followed
each resident for 12 months.
Measures
Trained independent research nurses recruited resi-
dents and collected demographic data, health informa-
tion, and drug use data from the medical and nursing
record and did standardised face to face interviews.
The primary outcomes were function, self reported
(late life function and disability instrument4) and
observed (timed up and go,5 elderly mobility scale6);
quality of life; and falls over 12 months of follow-up.
Secondary outcome measures were depressive
symptoms,7 fear of falling,8 and hospital admissions
over the 12 months of the trial (see bmj.com).
Interventions
Two trained gerontology nurses, one at each site,
delivered the promoting independence in residential
care (PIRC) intervention on the basis of a successful
efficacy trial.2
Goal setting—The resident, assisted by the gerontol-
ogy nurse, set a mutually agreed goal that had to meet
two criteria: it had to be relevant andmeaningful to the
resident, and it had to promote progressive increases in
physical activity.
Functional assessment and activity programme design—
The gerontology nurse then completed a functional
assessmentanddesignedan individualisedprogramme
of physical activities basedon repetitions of activities of
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daily living, such as rising from a chair, additional
walking, or repeated transfers. Exercise activities were
planned to be done daily or several times a day in short
doses. A prescriptive plan, the promoting indepen-
dence plan, was constructed and placed on the wall in
the resident’s room and in the resident’s file.
Staff implementation—The gerontology nurse trained
the healthcare assistants in implementing the promoting
independence plan on a one to one basis for each
resident.Thehealthcare assistants then implemented the
planunder thesupervisionof theusualnursingstaffof the
facility. For the more independent residents, the
healthcare assistants provided minimal supervision.
The more dependent residents needed up to
15 minutes of close supervision of the plan twice daily
(see bmj.com for a full description of the intervention).
Control group—Residents in control group homes
received usual care and were offered two social visits by
a social science researcher to control for the attention
receivedby the resident fromthegerontologynursevisits.
Statistical analysis
We used generalised linear mixed models, with rest
home as a random factor, city as a fixed factor, and time
as a repeated measure, to investigate whether the
intervention was associated with a change in function
or quality of life over time and in particular whether this
change differed between the social and intervention
groups.Weusedageneralised linearmixedmodelwitha
logit link for the secondary outcome of depression. We
investigated time to fall, allowing for multiple falls per
resident, by using a Cox proportional hazards model
with rest home includedas a randomeffect.We included
mental status, depression, age, sex, previous falls, total
numberof drugs (as a proxy forhealth status), time in the
low level dependency home, and socioeconomic status
in the models for the primary outcomes.
RESULTS
Forty one of 46 randomly selected homes participated;
83% of eligible residents participated (330 activity
Table 1 | Effect of an activity intervention on late life function and disability instrument disability




0-12 months 12 months P value
Disability overall:
0.25*Activity group 36.3 (0.6) −1.3 (0.6) 35.4 (0.6)
Social group 35.9 (0.5) −1.6 (0.4) 34.5 (0.6)
Limitation overall:
0.27Activity group 58.8 (1.4) −8.3 (1.9) 49.8 (1.5)
Social group 57.8 (1.3) −7.3 (2.0) 50.1 (1.4)
*For interaction between time and intervention group from repeated measures analysis comparing groups over
time; no interaction between cognition and intervention.
Table 2 | Effect of an activity intervention on function,mobility and balance, and quality of life. Values aremean (SE)




Activity group 44.5 (1.0) −0.8 (0.5) 43.9 (1.0) −0.2 (0.3) 43.6 (1.0)
Social group 44.9 (1.0) −2.2 (0.6) 42.7 (1.0) 0.3 (0.7) 43.0 (1.0)
Cognition impaired:
Activity group 46.7 (1.4) −2.1 (1.1) 44.4 (1.5) −2.8 (1.1) 42.5 (1.7)
Social control 47.1 (1.2) −0.3 (1.4) 47.1 (1.3) 0.2 (1.0) 46.8 (1.4)
Mobility and balance
TUG (seconds):
0.67Activity group 35.4 (2.1) 3.0 (1.5) 38.9 (2.2) 0.3 (1.4) 38.5 (2.3)
Social group 34.6 (2.0) 2.4 (1.0) 36.9 (2.1) 1.2 (0.5) 37.0 (2.1)
EMS (% score ≤16): (% increased:% decreased) (% increased:% decreased)
0.48Activity group 47.0 (4.01) 9:11 45.8 (4.2) 5:8 43.5 (4.4)
Social group 46.0 (3.9) 9:8 49.2 (4.0) 5:9 43.9 (4.1)
Balance (% ≥10 seconds
tandem stance):
(% increased:% decreased) (% increased:% decreased)
0.16Activity group 42.9 (4.0) 14:13 42.4 (4.4) 10:13 38.9 (4.7)
Social group 38.2 (3.8) 17:11 47.0 (4.1) 7:17 34.8 (4.3)
Quality of life
EuroQol (score/12):
0.49Activity group 9.7 (0.2) 0.2 (0.1) 9.9 (0.2) 0.2 (0.2) 10.0 (0.2)
Social group 9.6 (0.1) 0.3 (0.2) 10.0 (0.2) 0.2 (0.2) 10.1 (0.2)
LSI-Z (score/20):
0.35Activity group 15.3 (0.4) −0.4 (0.2) 14.7 (0.4) −0.3 (0.2) 14.5 (0.4)
Social group 14.9 (0.4) −0.3 (0.3) 14.6 (0.4) 0.3 (0.3) 14.9 (0.4)
*For interaction between time, cognition, and intervention group from repeated measures analysis.
EMS=elderly mobility scale (higher scores=better function); LLFDI=late life function and disability instruments; LSI-Z=life satisfaction index; TUG=timed
up and go test.
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group, 352 social group). The mean age of residents
was 84 (SD 7) years, and 504 (74%) residents were
women. Characteristics of residents were mainly
evenly balanced between the groups.
We found no evidence of interactions between
depression, group status, and time for any of the
primary outcomes. Therefore, all analyses include
residents with and without depression. No significant
interaction existed for the disability overall and
limitation overall scales of the late life function and
disability instrument (table 1).
A significant interaction existed between cognition
andgroup status for the functionoverall scale of the late
life function and disability instrument (P=0.024), and
we report the results separately for this variable. For
residents with normal cognition (abbreviated mental
test score ≥7) the activity group deteriorated less in
overall function (late life function and disability
instrument, total function component score) in the
first six months of follow-up (table 2). A similar
significant interaction (P=0.015) in the lower limb
subscale score of the late life function and disability
instrument showed a maintenance in score in the
activity group for those with normal cognition (inter-
vention group score 48.8 at baseline, 48.1 at six
months, and 47.7 at 12 months; control group 49.5,
45.9, and 46.5) but no differences in the cognitively
impaired subgroup. For those with impaired cognition
(abbreviated mental test score <7), the activity inter-
vention had no significant effect on function and the
mean scores for activity group participants tended to
deteriorate faster than those of the social group. Other
subscale scores, including advanced lower limb, upper
limb, overall disability, and social and personal role
subscales on the late life function and disability
instrument; mobility and balance measures; quality
of life; and time to fall, were not affected by the activity
intervention (see table 1 and bmj.com).
More people with impaired cognition in the activity
group had pronounced depressive symptoms after the
activity intervention than did those with cognitive
impairment in the social group (table 3). We did not
analyse fear of falling, as at least 40% of the sample had
incomplete data for thismeasure.Nodifference existed
in theproportionof residentswhowere either admitted
into higher level care or died during the 12 months of
the trial between the activity group (55/330, 17%) and
the social group (47/352, 13%) (P=0.61). We found no
evidence of a difference in the rate of hospital
admissions between the social group and the activity
group (P=0.55), nor any difference in the level of
adverse outcomes (P=0.75).
When we considered uptake of the intervention,
analyses found that thosewhoachieved their goal (187/
330, 57%)werenomore likely tohave an improvement
in function than those who did not (P=0.84). We were
unable to accurately ascertain to what degree the
promoting independence plan was adhered to. Inter-
vention nurses reported that 145 (44%) of the inter-
vention group residents did few or no activity sessions.
We foundnogreater change in outcomes for thosewith
greater compliance.
DISCUSSION
An activity programme had no impact on overall
function for elderly people in residential care. The
difference between the activity group and social group
in residents with normal cognition was of questionable
clinical significance, and no changes occurred in
observed function, quality of life, or falls. Neither
achievement of goals nor compliance made any
difference to improvement in function. Residents
with impaired cognition showed no maintenance of
function and may have become more depressed.
Other trials showing greater levels of success in
changing quality of life or performance based assess-
ments of mobility have tested more vigorous and
resource intensive interventions.9-12 The training
approach in this study focused on practising overall
functional tasks embedded within daily activities,
facilitated by existing staff. Unlike other studies, it did
not use anexercise focusedapproach to intensivelywork
Table 3 | Effect of activity intervention on depression and aches and pains (secondary outcome
measures) in older people in residential care
Secondary outcomes and
adverse events Baseline 6 months 12 months P value
Geriatric depression scale score >4 (% (SD))
Cognitively impaired:
0.004*
Activity group 41.9 (7.1) 48.5 (7.7) 63.8 (8.0)
Social group 38.4 (6.1) 35.2 (6.2) 35.9 (6.6)
Cognitively normal:
Activity group 37.1 (3.7) 37.5 (3.8) 37.9 (4.1)
Social group 44.5 (3.8) 46.8 (4.0) 49.0 (4.2)
Aches and pains (% (95% CI))
Activity group 48.8 (40.4 to 54.9) 46.7 (39.3 to 54.9) 42.4 (34.7 to 50.4)
0.75†
Social group 49.5 (42.6 to 56.5) 51.1 (43.8 to 58.4) 48.8 (41.2 to 56.6)
*P value for interaction between time, cognition, and intervention group from repeated measures analysis.
†P value for interaction between time and intervention group from repeated measures.
WHAT IS ALREADY KNOWN ON THIS TOPIC
Improvingactivity levels for elderlypeople in residential care
can improve quality of life but may increase falls
Sustainableways to improve activity in residential care have
not been identified
Few trials have tested functionally based activity
programmes in residential care
WHAT THIS STUDY ADDS
Agoal orientedprogrammebasedonactivities of daily living
madenoreal impressiononfunctionor falls inelderlypeople
in long term residential care
For those with impaired cognition this intervention was not
helpful and may have increased depressive symptoms
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on underlying impairments such as muscle weakness or
balance problems. This intervention also did not
consider any environmental barriers or psychological
factors thatmight need to be tackled to facilitate changes
at the level of disability or quality of life.
Conclusions
An activity programme based on usual activities of
daily living, targeted to a personal goal that is mean-
ingful to an individual resident, didnot help topreserve
physical function in frail elderly people with normal
cognition in residential care and may have adversely
affected those with poor cognition. Low compliance
with activity recommendations was likely. To be
successful, such interventions may need a higher
intensity of activity and more effective reinforcement
by care workers. Interventions should be carefully
targeted to those people likely to engage and respond
within the residential care context.
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Retrospective determination of whether famine existed in
Niger, 2005: two stage cluster survey
Avid Reza,1 Basia Tomczyk,1 Victor M Aguayo,2 Noel M Zagre´,3 Kadade´ Goumbi,4 Curtis Blanton,1
Leisel Talley1
ABSTRACT
Objective To apply the famine scale by Howe and
Devereux to the situation in Niger, west Africa, in 2005 to
retrospectively determine whether famine existed.
Design Two stage cluster survey.
Setting Survey of households in each of Niger’s eight
regions.
Participants 4003 households.
Main outcome measures Crude mortality, mortality in
children under 5, and the proportion of caregivers
adopting coping strategies to deal with insufficient food
needs, nationally and regionally.
Results The estimated national crude mortality rate was
0.4 (0.4 to 0.5) deaths per 10 000 per day and under 5
mortality rate was 1.7 (1.4 to 1.9) deaths per 10 000 per
day. Nationally, 22.3% (95%confidence interval 19.9% to
24.8%) of caregivers of under 5s did not resort to any
coping strategies to deal with insufficient food needs.
Reversible coping strategieswere, however, usedby 5.8%
(4.7% to 7.0%) of caregivers, whereas 49.4% (46.9% to
51.8%) relied on irreversible coping strategies and 22.6%
(20.0% to 25.4%) on survival strategies.
Conclusion On the basis of the famine scale proposed by
Howe and Devereux, most regions in Niger experienced
food crisis conditions and someareas approached famine
proportions.
INTRODUCTION
The absence of universal benchmarks or criteria to
identify famine conditions creates uncertainty about
the magnitude of a crisis, resulting in delays and
inappropriate responses.1 2 The scale proposed by
Howe and Devereux offers an approach to defining
famine, based on intensity and magnitude.1 2 The
intensity scale involves a combination of anthropo-
metric andmortality indicators and descriptors of food
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security (coping strategies, stability of the market and
food prices) and ascribes a level from 0 (food secure
conditions) to 5 (extreme famine conditions) in
population areas within a country. The magnitude
scale is determined retrospectively by measuring
excess mortality caused by the entire crisis.
Media reports left little doubtof ahumanitarian crisis
in Niger, west Africa, in 2005 but the scale and severity
of the crisis andwhether it reached famine proportions
was disputed. We applied the scale to the crisis to
determine if famine had occurred.
METHODS
We carried out surveys in Niger’s eight regions:
Agadez, Diffa, Dosso, Maradi, Tahoua, Tillaberi,
Zinder, and the capital Niamey. We used a stratified
two stage cluster survey design: we first selected 26
village level clusters in each region then used
systematic random sampling to select 20 households
per cluster.
To estimate mortality we included all selected
households, regardless of whether they included a
child aged 6 to 59 months. The head of the household
completed a questionnaire, including a census of the
household. The remainder of the questionnaire was
administered to caregivers of children under 5 in the
household, which asked about the strategies used to
copewith insufficient foodneeds since the beginningof
the last “hungry season” in 2005. We also collected
anthropometric measurements on children aged 6 to
59 months.
The census was taken to determine the number of
people and under 5s present in the household since 21
January 2005—the day of Tabaski, a major religious
event. We recorded deaths in the household between
21 January 2005 and the date of the interview, and the
month of death. A series of structured questions were
used to assign cause of death among under 5s into one
of eight categories on the basis of a verbal autopsy.3We
also asked questions on the child’s appearance at the
time of death to determine if malnutrition may have
contributed.
We stratified the coping strategies for dealing with
insufficient food needs into four categories: no coping
strategies, reversible adaptive strategies, irreversible
coping strategies, and survival strategies (seebmj.com).
On the basis of the caregivers’ responses we assigned
each caregiver to one of the categories. We estimated
the proportion of caregivers both regionally and
nationally adopting each strategy.
To account for weighting of the variables and the
complex sample design we used SAS callable
SUDAAN version 9.01. We calculated sampling
weights by multiplying the inverse probability for
selectionof apersonwithinahouseholdmultipliedbya
post-stratification adjustment on the basis of the census
population of the region. The procedure Proc Ratio
was used to compute 95% confidence intervals for
mortality.We based the number of recall days for each
personon thedateof the interviewminus the start of the
recall period (21 January 2005). For live births and
deaths during the recall period we estimated the
number of recall days as half of the recall period. For
proportions we computed confidence intervals using
Proc Crosstab. To test the difference in coping
strategies between urban and rural regions we ran a t
test using Proc Descript.
RESULTS
From 17 September to 14 October 2005 data were
collected by survey from 4003 of 4160 households.
Information on health was gathered on 5309 children
under 5. The mean size of households was 6.9, and
under 5s constituted 21.0% of household members.
Theestimatedcrudemortality ratenationallywas0.4
deaths per 10 000 per day (95% confidence interval 0.4
to 0.5) whereas regionally it ranged from0.2 deaths per
10 000 per day (0.1 to 0.3) in Agadez to 0.7 deaths per
10 000per day (0.5 to 0.9) inZinder (see bmj.com).The
under 5 mortality rate nationally was 1.7 (1.4 to 1.9)
deaths per 10 000 per day whereas regionally it ranged
from 0.3 (0.1 to 0.7) deaths per 10 000 per day in
Agadez to 2.2 (1.4 to 3.0) deaths per 10 000 per day in
Zinder (see bmj.com).
Most deaths from known causes in under 5s
nationally were reported as diarrhoea (30.2%, 95%
confidence interval 22.7% to 38.8%), acute respiratory
illness (20.1%, 13.6% to 28.6%), andmeningitis (14.1%,
9.7% to 20.1%). Insufficient sample size prevented the
determination of regional variations. Of the children
who died during the recall period, 51.6% (42.2%
to 61.0%) were perceived by their caregiver as
malnourished.
Coping strategies
Since the beginning of the last hungry season coping
strategies were not used by 22.3% (19.9% to 24.8%) of
caregivers nationally (see bmj.com). Also nationally
5.8% (4.7% to 7.0%) of caregivers of under 5s relied
on reversible coping strategies, whereas 49.4%
(46.9% to 51.8%) relied on irreversible coping
strategies and 22.6% (20.0% to 25.4%) on survival
strategies.A similar patternwas observed in the seven
predominantly rural regions, with most caregivers
relying on irreversible coping strategies: the propor-
tion of caregivers relying on such strategies varied
from 35.4% (28.3% to 43.1%) in Agadez to 64.7%
(58.7% to 70.3%) in Zinder, and the proportion
relying on survival strategies ranged from 14.2%
(9.7% to 20.4%) in Diffa to 33.0% (24.4% to 43.0%) in
Maradi. In contrast with the predominantly rural
regions, 56.2% (49.8% to 62.4%) of caregivers in
Niamey did not use any coping strategies. Compared
with each of the other seven regions, the proportion
of caregivers in Niamey not using any coping
strategies differed statistically (P<0.001 for all seven
t tests).
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DISCUSSION
Using the famine scale by Howe and Devereux we
retrospectively determined that a food crisis was under
way at the time of the household survey inNiger, 2005.
This affected children in each region.4 In four of the
eight regions the prevalence of global acute malnutri-
tion among children aged 6 to 59months exceeded the
critical threshold of 15% established by WHO.5
Despite the critical levels of acute malnutrition
reported in Diffa, Maradi, Tahoua, and Zinder,4 the
prevalence of global acute malnutrition in these
regions during the surveywas below the 20% threshold
(famine conditions).1 The levels of global acute
malnutrition in these four regions were consistent
with food crisis conditions. Furthermore, crude mor-
tality rates nationally and regionally remained below
the benchmark of 1 death per 10 000 per day, as
required for famine conditions.1 The crude mortality
rates in Tahoua, Tillaberi, and Zinder was between 0.5
and 1 death per 10 000 per day—consistent with food
crisis conditions, whereas the remaining regions
experienced crude mortality rates consistent with
conditions for food insecurity. Although crude mor-
tality rates did not indicate famine, the survey results
suggest that malnutrition did play an important part in
child mortality, given that 51.6% (95% confidence
interval 42.2% to 61.0%) of under 5s who died during
the recall period were reported by their caregivers as
malnourished. In comparison, 15.6% of the global
deaths among under 5s in 1994 were attributed to
malnutrition.6 The anthropometry and mortality
indicators suggest that Diffa, Maradi, Tahoua, Tilla-
beri, and Zinder experienced food crisis conditions,
whereas the remaining three regions experienced food
insecurity conditions.
At the onset of the crisis, food insecurity was
undoubtedly a problem; disagreement remained,
however, about the magnitude of the crisis.7 8 The
food security assessment carried out in April 2005 by
the government of Niger, the Food and Agricultural
Organisation, the World Food Program, and the
Famine Early Warning Systems Network indicated
that about 67% of the people living in agropastoral
areas were highly vulnerable to food insecurity.8
Coverage by the media and reports from non-
governmental organisations claimed famine condi-
tions, but the joint food security assessment concluded
that the crisis did not reach famine proportions.8
The survey results show that during the crisis more
than 50% of caregivers of under 5s in all regions except
Niamey relied on irreversible or survival coping
strategies. In all regions except Niamey irreversible
coping strategieswere themost commonmeans to deal
with the crisis. According to the famine scale, the
adoption of such strategies is consistent with a food
crisis.1 In Agadez, Maradi, Tahoua, Tillaberi, and
Zinder, however,more than20%of caregivers of under
5s resorted to survival strategies. Although the famine
intensity scale does not specify what percentage of the
affected population has to rely on survival strategies to
constitute famine conditions, the large proportion of
caregivers using survival strategies seems to indicate
that in some regions famine may have been imminent.
During the crisis many raised concerns that Unicef,
non-governmental organisations, and the media were
exaggerating the magnitude of the situation.8 Our
results indicate that the crisis was not just localised but
widespread. Most regions experienced food crisis
conditions, and the adoption of survival strategies by
caregivers further suggests that many regions were
potentially on the threshold of a famine.
Limitations
Our studyhas several limitations. Firstly, an estimate of
retrospective mortality is subject to recall bias. We
attempted to minimise this bias by limiting the recall
period toeightmonths andbydefining thebeginningof
the period using Tabaski, a well known religious
holiday. Secondly, we relied on oral reports of house-
holdmembers to determine cause of death in under 5s.
Althoughweuseda seriesof structuredquestionsbased
on theWHOcriteria for verbal autopsy to improve the
accuracy of the data and to help classify cause of death,
some misclassification may have occurred. Thirdly,
questions on household coping strategies were admi-
nistered to caregivers of under 5s, therefore these
results are not representative of all households
nationally. Finally, in the absence of an agreed and
standardised analysis tool for assessing coping strate-
gies, we consolidated these strategies into mutually
exclusive categories and assigned each respondent to
one of them.This approach does not, however, capture
the complex range of strategies to which each house-
hold resorted.
Conclusion
On the basis of the famine scale by Howe and
Devereux, most regions in Niger in 2005 experienced
food crisis conditions and some areas approached
famine proportions. The absence of a universally
accepted definition of famine contributed to disagree-
ments about the magnitude and severity of the
problem. Although the utility of the scale needs
rigorous assessment, it does provide more objective
WHAT IS ALREADY KNOWN ON THIS TOPIC
A lack of universal criteria to identify famine creates
uncertainty about the size of the crisis, resulting in delays
and inappropriate responses
The scale and severity of the food crisis in Niger in 2005 and
whether it reached famine proportions was disputed
WHAT THIS STUDY ADDS
On the basis of the famine scale by Howe and Devereux,
most regions in Niger in 2005 experienced food crisis
conditions, and some areas approached famine
The scale provides more objective criteria than do previous
approaches and along with early warning systemsmay help
guide the level of response
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criteria than previous approaches. It alsomoves from a
binary concept of “famine” or “no famine” to a
graduated approach that captures a range of food
insecurity situations.1Onepotential useof the scale is in
conjunction with early warning systems, to help guide
the level of humanitarian response and to provide a
greater opportunity to recognise a potential famine.2 A
determination of the scale and severity of a crisis and
whether it reaches famine proportions is important for
ensuring a proportionate and timely response.
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Overuse of tympanostomy tubes in New York metropolitan
area: evidence from five hospital cohort
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ABSTRACT
Objectives To compare tympanostomy tube insertion for
children with otitis media in 2002 with the
recommendations of two sets of expert guidelines.
Design Retrospective cohort study.
Setting New York metropolitan area practices associated
with five diverse hospitals.
Participants 682 of 1046 children who received
tympanostomy tubes in the five hospitals for whomcharts
from the hospital, primary care physician, and
otolaryngologist could be accessed.
Results The mean age was 3.8 years. On average, children
with acute otitismedia had fewer than four infections in the
year before surgery. Childrenwith otitismediawith effusion
had less than 30 consecutive days of effusion at the time of
surgery. Concordancewith recommendations was very low:
30.3%(n=207)ofall tympanostomieswereconcordantwith
the explicit criteria developed for this study and 7.5%
(n=13)with the1994guideline from theAmericanAcademy
of Pediatrics, American Academy of Family Medicine, and
American Academy of Otolaryngology—Head and Neck
Surgery. Children who had previously had tympanostomy
tube surgery, whowere having a concomitant procedure, or
who had “at risk conditions” were more likely to be
discordant.
Conclusions A significant majority of tympanostomy tube
insertions in the largest and most populous metropolitan
area in theUnitedStateswere inappropriate according to the
explicit criteria and not recommended according to both
guidelines.Regardlessofwhethercurrentpractice represents
a substantial overuse of surgery or the guidelines are overly
restrictive, the persistent discrepancy between guidelines
and practice cannot be good for children or for people
interested in improving their health care.
INTRODUCTION
Otitis media is the most common illness for which
children present to the doctor, and tympanostomy
tubes are the most common reason for general
anaesthesia in children.1-3 Only one study has exam-
ined the appropriateness of insertion of tympanostomy
tubes in children.4 5 This study, published in 1994,
reported that less than half of surgeries among children
in the United States were appropriate.
We compared the clinical characteristics of the
children in our studywith the recommended indications
for surgery as codified by the prevailing guideline (1994)
at that timeanda set of explicit criteria thatwedeveloped
specifically for this study in2000.Toourknowledge, this
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is the first study to examine the appropriateness of
insertion of tympanostomy tubes with data collected by
independent audits of the records.
METHODS
Study population and data
We did a retrospective cohort study and collected
detailed data for a one year period before insertion of a
tympanostomy tube for each child.6 We developed an
electronic tool to assist data collection for chart audits
of all 1046 children less than 18 years old who were
identified by hospital administrative databases as
having received tympanostomy in any of five New
York metropolitan area hospitals in 2002. This manu-
script reports on those 682 children for whomwewere
able to audit all three medical records: from the
primary care physician’s office, the otolaryngologist’s
office, and the hospital.
Development of explicit criteria
The RAND appropriateness method uses a two round
modified Delphi process to integrate literature with
expert opinion into explicit criteria.7 We convened an
expert panel of four otolaryngologists, four paediatri-
cians, and one family physician and provided them
with a detailed literature review. The panel identified
relevant clinical factors that we organised into an
exhaustive and mutually exclusive list of potential
clinical scenarios to represent the range of circum-
stances that might present to a clinician. The panellists
then rated the appropriateness of each scenario (see
bmj.com).
The 1994 academy guideline was developed inde-
pendently of this study by three clinical societies and
was published as a clinical practice guideline by theUS
Agency for Health Care Policy and Research.8 The
1994 guideline was limited to “healthy” children from
their first birthday until before they turn 4 and suggests
that insertion of a tympanostomy tube is optional after
three months of persistent effusion with bilateral
hearing loss and is recommended after four to six
months of bilateral effusion.
Analysis
Wemapped each child to the detailed clinical scenario
rated by the panel that was consistentwith the details of
the clinical history.Wealso comparedpracticewith the
1994 academy guideline. As no national guidelines on
the surgicalmanagement of acute otitis media exist, we
limited our analysis to children with otitis media with
effusion.
We also examined how alternatives to our expert
panel’s judgment would affect the appropriateness
ratings for the treatment of children with acute otitis
media. Finally, we looked at the relation to appropri-
ateness of the presence of conditions that would place a
child at risk for poor outcomes, a history of tympa-
nostomy tube surgery, and other procedures done at
the time of tympanostomy tube surgery.5
RESULTS
Children’s mean age was 3.8 years, and 61% were
white. More than a quarter (26.5%) of children had
previously received tubes, and 21.7% had another
surgery done concurrently with the insertion of a
tympanostomy tube; 17.3% of children had a clinical
condition that could be considered to place them “at
risk” of poor developmental outcomes (see bmj.com).
Children with acute otitis media on average had about
three infections in the six months before tympanost-
omy. Children with otitis media with effusion had less
than 30 consecutive days of bilateral effusion before
tympanostomy (table 1). Only 25% of children with
otitis media with effusion had bilateral effusions of
more than 49 days’ duration at surgery. More than a
Table 1 | Clinical characteristics of cohort (year before tympanostomy)
Characteristics Mean (SE) Median (interquartile range)
Episodes of infection*
6 months before tympanostomy 3.1 (0.1) 3 (2-4)
1 year before tympanostomy 4.6 (0.1) 4 (3-6)
Length of effusion†
Consecutive days of effusion‡:
Bilateral 30.7 (1.7) 16 (0-49)
Unilateral (left) 39.1 (2.0) 26 (2-63.5)
Unilateral (right) 39.8 (2.0) 28 (3-63.5)
Cumulative days of effusion§:
Bilateral 77 (2.9) 66 (30-109.5)
Unilateral (left) 91.7 (3.2) 78.5 (40.5-131.5)
Unilateral (right) 96.8 (3.1) 88 (46.5-138)
*Children with acute otitis media (n=230).
†Children with otitis media with effusion (n=452).
‡Refers to effusion directly preceding surgery.
§Cumulative effusion over one year




Ratings according to explicit criteria
All children (n=682) 48 (7.0) 159 (23.3) 475 (69.7)
Acute otitis media (n=230) 9 (3.9) 110 (47.8) 111 (48.3)
Otitis media with effusion (n=452) 39 (8.6) 49 (10.8) 364 (80.6)
All children: criteria modified to eliminate
preference for antibiotic prophylaxis* (n=682)
150 (21.9) 57 (8.3) 475 (69.7)
Excluding cases with potentially extenuating
circumstances† (n=341)
31 (9.1) 104 (30.5) 206 (60.4)
Academy guidelines‡
1994 Academy guidelines (n=172) 13 (7.5) 159 (92.5)
1994Academyguidelines (age>1year) (n=533) 30 (5.6) 503 (94.4)
*The expert panel considered indication for surgery for recurrent acute otitis media to be of uncertain
appropriateness if no antibiotic prophylaxis was used to suppress reoccurrence; this analysis elevates the
ratings for surgeries that failed to meet this aspect of the criteria from uncertain to appropriate (a potentially
alternative view); no official guidelines on the surgical treatment of acute otitis media exist.
†Such as history of previous tubes, other surgery/procedure at time of tube insertion and “at risk conditions”;
the expert panel considered only the nature and magnitude of ear disease in the decision to insert tubes and not
consider these extenuating circumstances.
‡The 1994 Academy guideline covers the management of otitis media with effusion, not recurrent acute otitis
media.
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quarter of children who had surgery had normal
audiograms.6
Of 2268 potential clinical scenarios, we saw 220
(9.7%) in clinical practice (see bmj.com). The explicit
criteria classified 7.0% (48 cases) of actual surgeries as
appropriate, 23.3% (159 cases) as of uncertain appro-
priateness, and 69.7% (475 cases) as inappropriate
(table 2). Cases that were classified as appropriate,
uncertain, and inappropriate had on average 80, 38,
and18daysof effusion.Counting surgeries classified as
appropriate or uncertain as concordant, 30.3% were
concordant with the explicit criteria. We found no
statistically significant differences in appropriateness
between hospitals.
Among children with effusion as the reason for
surgery, 76% of the inappropriate cases were inap-
propriate primarily owing to the short duration of the
effusion immediately preceding surgery. Low fre-
quency of infection was the most common reason
why the cases with acute otitis media were not
concordant with the explicit criteria. In the analysis
based on academy guidelines, the main reason for
discordance with the guideline was again short dura-
tion of effusion.
In an additional analysis, we excluded all children
with potentially extenuating circumstances. We found
that the explicit criteria would consider 9.1% of the
surgeries to be appropriate, 30.5% to be of uncertain
appropriateness, and 60.4% to be inappropriate. Thus
even in a liberal review, more than 60% of cases were
not concordant with the panel’s findings (table 2). Not
surprisingly, concordance with the criteria also was
lower for children ineachof these three subpopulations
than for the population as a whole (table 3).
DISCUSSION
We found that tympanostomy tubes in the United
States are often used in a manner inconsistent with
expert recommendations.
Implications
The finding that 69% of cases deviated from the
practices specifically developed for this study—or that
more than 92% of surgeries would have been “not
recommended” according to the guideline in force at
the time of the surgery—suggests considerable overuse
of this procedure. Historically, the major benefit of
tympanostomy tubes discussed in the literature per-
tains to speech and language development. Recent
research provides strong evidence that delay in the
insertion of tympanostomy tubes is not associatedwith
worse behavioural or developmental outcomes.9 10
However, these findingsdonot imply that tubes should
be avoided or that there are not health systems for
which tubes may be underused.
Limited evidence shows that tubes improve disease
specific quality of life.11-13 If tubesdomake children feel
better or otherwise improve the quality of their lives in
the short term, then the emphasis on long term
outcomes and development that has predominated in
the guideline may not be sufficient.
Our data show that otolaryngologists treat children
differently if they have one or more of three specific
circumstances—a history of previously having had
tympanostomy tubes, the scheduling of a concomitant
surgery, and the presence of one or more of the
conditions we identified as putting a child “at risk.”
About half of our sample had one or more of these
circumstances present. The extent to which these
circumstances should be extenuating is questionable.
Limitations
In this study, we focused only on children who had
received tubes; we did not consider the possible
underuse of tympanostomy in some populations. Our
timing during implementation of a US federal privacy
rule restrictedour access to charts for about one third of
children. However, even considering the most gener-
ous assumption that insertion of a tympanostomy tube
was appropriate for every child with data missing,
more than 40% of cases would still be considered
inappropriate.
Tomake assessments about the courseof otitismedia
we needed to translate the intermittent clinical assess-
ments available from the charts into the continuous
variables (days of effusion) that we used in our analysis.
Table 3 | Variability of concordancewith explicit criteria
Subpopulations of children Concordant (%) P value
All children (n=682) 207 (30.3)
At risk*
<0.0001Yes (n=118) 18 (15.2)
No (n=564) 189 (33.5)
Concomitant procedure:
<0.05Yes (n=148) 34 (22.9)
No (n=534) 173 (32.4)
History of tympanostomy tubes:
<0.001Yes (n=181) 37 (20.4)
No (n= 501) 170 (33.9)
*Includes children with hearing loss independent of otitis media with effusion; language or speech disorder;
autism and other developmental symptoms; Down’s syndrome or other craniofacial syndromes that include
cognitive, speech, or language delay, visual impairment, cleft palate, and developmental delay.
WHAT IS ALREADY KNOWN ON THIS TOPIC
Tympanostomy tubes are used commonly in the United
States to treat otitis media, whereas in the UK this practice
has been reduced
A 1994 study which suggested that inappropriate use was
common in the US was controversial because of its data
sources and the criteria used
WHAT THIS STUDY ADDS
Most insertions of tympanostomy tubes in the New York
metropolitan area were for inappropriate reasons according
to two different standards
These findings suggest a serious discrepancy between the
clinical care of children and the recommendations that
experts suggest should be the standard of care in the US
RESEARCH
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The need to impute findings is an unavoidable
limitation; however, we made generous clinical
assumptions that would favour a longer duration of
effusion and concordance with the explicit criteria and
the academy guideline (see bmj.com).
Conclusions
Regardless of whether current practice represents a
substantial overuse of surgery or the guidelines are
overly restrictive, the persistent discrepancy between
guidelines and clinical practice cannot be good either
for children or for those interested in improving their
health. Substantial overuse would expose children to
riskandconsumeresources that couldbebetter applied
to otherwise improving the health of children. Erro-
neous guidelines could lead clinicians, policy makers,
and researchers to ill advised interventions and under-
mine the value of guidelines in general. Given the
ubiquity of this disease and its surgical treatment,
resolution of these issues should represent an urgent
priority. The UK experience may prove a useful
resource for policy makers in the United States as they
take on these challenges.
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Dangerously ill list patient
After completing my medical studies 27 years ago, I was
posted to a government hospital as a medical officer. On
my first dayonduty as the emergencymedical officer Iwas
told by a senior matron that I had to conduct rounds of all
the wards and write progress notes for all the patients on
the dangerously ill list.
I started the ward rounds in earnest. In a remote corner
of the sprawling, colonial era hospital, I entered a high
ceilinged ward that was deserted except for a steel bed in
the centre of the room. Placed in the centre of thebedwas a
table, on topofwhichwas a stool. Standingon the stoolwas
a young man, and perched on his shoulders was another
youngman, who was cleaning the ceiling fan as part of the
preparations for a forthcoming hospital inspection. It was
pointed out to me by the nursing officer in charge of the
ward that the young man cleaning the fan was on the
dangerously ill list.
When I asked the patient about his diagnosis
and progress, he confirmed being on the dangerously
ill list for anaemia—his haemoglobin concentration
was 90 g/l. The nursing officer informed me that,
according to the existing medical services rules (framed
in the era of British rule), all patients with haemoglobin
levels below 100 g/l had to be placed on the dangerously
ill list.
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